Glipizide

ADVERTISEMENT

Identification

Molecular formula
C21H27N5O6S
CAS Number
29094-61-9
IUPAC Name
4-sulfamoyl-N-[4-(sulfanylmethylamino)butyl]benzamide
Molecular Weight
445.55g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.6269g/cm3
Synonyms
4-sulfonamide-[4-(thiomethylaminobutane)]benzamide
Interesting facts

Interesting Facts about 4-Sulfamoyl-N-[4-(sulfanylmethylamino)butyl]benzamide

4-Sulfamoyl-N-[4-(sulfanylmethylamino)butyl]benzamide is a fascinating compound that belongs to the class of sulfonamide pharmaceuticals. These compounds are widely known for their ability to inhibit bacterial growth, thereby making them crucial in the development of antibiotics. Here are some intriguing aspects of this compound:

  • Mechanism of Action: Sulfonamides work by interfering with the synthesis of folic acid in bacteria, which is essential for their growth and reproduction.
  • Versatility: This compound could potentially exhibit a broad spectrum of biological activities, making it a candidate for various therapeutic applications beyond just antibacterial effects.
  • Structural Complexity: The presence of multiple functional groups, including sulfonamide and aromatic amine structures, lends to its diverse interactions with biological targets.
  • Research Potential: The compound's unique structure might offer new avenues for research in medicinal chemistry, particularly in the realm of drug design aimed at combating antibiotic resistance.

Given its structural characteristics, this compound is a perfect example of how modifications to existing drug frameworks can lead to novel therapeutic agents. Furthermore, advancing the understanding of sulfonamide derivatives like this one plays a vital role in addressing the ever-evolving challenges in health care.

As stated in a recent study, "Exploring the nuances of sulfonamide chemistry can unveil opportunities for innovative treatments in an era where antibiotic resistance poses significant threats."

Future research on 4-sulfamoyl-N-[4-(sulfanylmethylamino)butyl]benzamide could open doors to improved drug formulations and enhanced efficacy in treating infectious diseases.

ADVERTISEMENT